<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37509643</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Role of the Renin-Angiotensin System in Long COVID's Cardiovascular Injuries.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2004</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines11072004</ELocationID><Abstract><AbstractText>The renin-angiotensin system (RAS) is one of the biggest challenges of cardiovascular medicine. The significance of the RAS in the chronic progression of SARS-CoV-2 infection and its consequences is one of the topics that are currently being mostly discussed. SARS-CoV-2 undermines the balance between beneficial and harmful RAS pathways. The level of soluble ACE2 and membrane-bound ACE2 are both upregulated by the endocytosis of the SARS-CoV-2/ACE2 complex and the tumor necrosis factor (TNF)-&#x3b1;-converting enzyme (ADAM17)-induced cleavage. Through the link between RAS and the processes of proliferation, the processes of fibrous remodelling of the myocardium are initiated from the acute phase of the disease, continuing into the long COVID stage. In the long term, RAS dysfunction may cause an impairment of its beneficial effects leading to thromboembolic processes and a reduction in perfusion of target organs. The main aspects of ACE2-a key pathogenic role in COVID-19 as well as the mechanisms of RAS involvement in COVID cardiovascular injuries are studied. Therapeutic directions that can be currently anticipated in relation to the various pathogenic pathways of progression of cardiovascular damage in patients with longCOVID have also been outlined.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cojocaru</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-0033-4620</Identifier><AffiliationInfo><Affiliation>Morpho-Functional Sciences II Department, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cojocaru</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9933-8965</Identifier><AffiliationInfo><Affiliation>Medical III Department, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vlad</LastName><ForeName>Cristiana-Elena</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Medical II Department, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>"Dr. C. I. Parhon" Clinical Hospital, 700503 Iasi, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eva</LastName><ForeName>Lucian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Faculty of Dental Medicine, "Apollonia" University of Iasi, 700511 Iasi, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>"Prof. Dr. Nicolae Oblu" Clinic Emergency Hospital, 700309 Iasi, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">angiotensin II</Keyword><Keyword MajorTopicYN="N">cardiovascular system</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">renin-angiotensin system</Keyword><Keyword MajorTopicYN="N">signal transduction</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37509643</ArticleId><ArticleId IdType="pmc">PMC10377338</ArticleId><ArticleId IdType="doi">10.3390/biomedicines11072004</ArticleId><ArticleId IdType="pii">biomedicines11072004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  Coronavirus Disease (COVID-19) Pandemic.  [(accessed on 6 June 2023)].  Available online:  https://www.who.int/europe/emergencies/situations/covid-19.</Citation></Reference><Reference><Citation>World Health Organization  Weekly Epidemiological Update on COVID-19&#x2014;8 June 2023.  [(accessed on 9 June 2023)].  Available online:  https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---8-june-2023.</Citation></Reference><Reference><Citation>World Health Organization  Post COVID-19 Condition (Long COVID)  [(accessed on 10 June 2023)].  Available online:  https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition.</Citation></Reference><Reference><Citation>Thaweethai T., Jolley S.E., Karlson E.W., Levitan E.B., Levy B., McComsey G.A., McCorkell L., Nadkarni G.N., Parthasarathy S., Singhe U., et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023;329:1934&#x2013;1946. doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. As Their Numbers Grow, COVID-19 &#x201c;Long Haulers&#x201d; Stump Experts. JAMA. 2020;324:1381&#x2013;1383. doi: 10.1001/jama.2020.17709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17709</ArticleId><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID.gov&#x2014;What Is Long COVID.  [(accessed on 10 June 2023)]; Available online:  https://www.covid.gov/longcovid/definitions.</Citation></Reference><Reference><Citation>Ballering A.V., van Zon S.K.R., Olde Hartman T.C., Rosmalen J.G.M. Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. Lancet. 2022;400:452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V. Long COVID-19, Challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab. Syndr. 2021;15:145&#x2013;146. doi: 10.1016/j.dsx.2020.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney L.L., Routen A., Gillies C., Ekezie W., Welford A., Zhang A., Karamchandani U., Simms-Williams N., Cassambai S., Ardavani A., et al. The prevalence and long-term health effects of Long COVID among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Xiao X., Wei X., Li J., Yang J., Tan H., Zhu J., Zhang Q., Wu J., Liu L., et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J. Med. Virol. 2020;92:595&#x2013;601. doi: 10.1002/jmv.25726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25726</ArticleId><ArticleId IdType="pmc">PMC7228221</ArticleId><ArticleId IdType="pubmed">32100877</ArticleId></ArticleIdList></Reference><Reference><Citation>Driggin E., Madhavan M.V., Bikdeli B., Chuich T., Laracy J., Biondi-Zoccai G., Brown T.S., Der Nigoghossian C., Zidar D.A., Haythe J., et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems during the COVID-19 Pandemic. J. Am. Coll. Cardiol. 2020;75:2352&#x2013;2371. doi: 10.1016/j.jacc.2020.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7198856</ArticleId><ArticleId IdType="pubmed">32201335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bavishi C., Bonow R.O., Trivedi V., Abbott J.D., Messerli F.H., Bhatt D.L. Special Article&#x2014;Acute myocardial injury in patients hospitalized with COVID-19 infection: A review. Prog. Cardiovasc. Dis. 2020;63:682&#x2013;689. doi: 10.1016/j.pcad.2020.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7274977</ArticleId><ArticleId IdType="pubmed">32512122</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell D.J. Clinical relevance of local Renin Angiotensin systems. Front. Endocrinol. 2014;14:113. doi: 10.3389/fendo.2014.00113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2014.00113</ArticleId><ArticleId IdType="pmc">PMC4095645</ArticleId><ArticleId IdType="pubmed">25071727</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W.A., Turner L., Marentes Ruiz C.J., Tanaka M.L., Congrave-Wilson Z., Lee Y., Jumarang J., Perez S., Peralta A., Pannaraj P.S. Clinical manifestations of COVID-19 differ by age and obesity status. Influenza Other Respir. Viruses. 2022;16:255&#x2013;264. doi: 10.1111/irv.12918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12918</ArticleId><ArticleId IdType="pmc">PMC8652925</ArticleId><ArticleId IdType="pubmed">34668322</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaduganathan M., Vardeny O., Michel T., McMurray J.J.V., Pfeffer M.A., Solomon S.D. Renin&#x2013;Angiotensin&#x2013;Aldosterone System Inhibitors in Patients with COVID-19. N. Eng. J. Med. 2020;382:1653&#x2013;1659. doi: 10.1056/NEJMsr2005760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsr2005760</ArticleId><ArticleId IdType="pmc">PMC7121452</ArticleId><ArticleId IdType="pubmed">32227760</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa L.B., Perez L.G., Palmeira V.A., Macedo e Cordeiro T., Teatini Ribeiro V., Lanza K., Sim&#xf5;es e Silva A.C. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System. Front. Cell Dev. Biol. 2020;8:559841. doi: 10.3389/fcell.2020.559841.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.559841</ArticleId><ArticleId IdType="pmc">PMC7525006</ArticleId><ArticleId IdType="pubmed">33042994</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhullar S.K., Dhalla N.S. Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy. Cells. 2022;11:3336. doi: 10.3390/cells11213336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11213336</ArticleId><ArticleId IdType="pmc">PMC9657342</ArticleId><ArticleId IdType="pubmed">36359731</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumbers E.R., Head R., Smith G.R., Delforce S.J., Jarrott B., Martin J.H., Pringle K.G. The interacting physiology of COVID-19 and the renin- angiotensin-aldosterone system: Key agents for treatment. Pharmacol. Res. Perspect. 2022;10:e00917. doi: 10.1002/prp2.917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.917</ArticleId><ArticleId IdType="pmc">PMC8929333</ArticleId><ArticleId IdType="pubmed">35106954</ArticleId></ArticleIdList></Reference><Reference><Citation>Simko F., Hrenak J., Adamcova M., Paulis L. Renin-Angiotensin-Aldosterone System: Friend or Foe-The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions. Int. J. Mol. Sci. 2021;22:3217. doi: 10.3390/ijms22063217.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22063217</ArticleId><ArticleId IdType="pmc">PMC8004737</ArticleId><ArticleId IdType="pubmed">33809971</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni W., Yang X., Yang D., Bao J., Li R., Xiao Y., Hou C., Wang H., Liu J., Yang D., et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit. Care. 2020;24:422. doi: 10.1186/s13054-020-03120-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03120-0</ArticleId><ArticleId IdType="pmc">PMC7356137</ArticleId><ArticleId IdType="pubmed">32660650</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Heurich A., Hofmann-Winkler H., Gierer S., Liepold T., Jahn O., P&#xf6;hlmann S. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J. Virol. 2014;88:1293&#x2013;1307. doi: 10.1128/JVI.02202-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02202-13</ArticleId><ArticleId IdType="pmc">PMC3911672</ArticleId><ArticleId IdType="pubmed">24227843</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu. Rev. Virol. 2016;3:237&#x2013;261. doi: 10.1146/annurev-virology-110615-042301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-110615-042301</ArticleId><ArticleId IdType="pmc">PMC5457962</ArticleId><ArticleId IdType="pubmed">27578435</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabassum A., Iqbal M.S., Sultan S., Alhuthali R.A., Alshubaili D.I., Sayyam R.S., Abyad L.M., Qasem A.H., Arbaeen A. Dysregulated Bradykinin: Mystery in the Pathogenesis of COVID-19. Mediat. Inflamm. 2022;2022:7423537. doi: 10.1155/2022/7423537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/7423537</ArticleId><ArticleId IdType="pmc">PMC8826266</ArticleId><ArticleId IdType="pubmed">35153624</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D.A., L&#xfc;scher T.F., Neubauer S. Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 2022;43:1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Maas C., Renne T. Coagulation factor XII in thrombosis and inflammation. Blood. 2018;131:1903&#x2013;1909. doi: 10.1182/blood-2017-04-569111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2017-04-569111</ArticleId><ArticleId IdType="pubmed">29483100</ArticleId></ArticleIdList></Reference><Reference><Citation>Schieffer E., Schieffer B. The rationale for the treatment of long-COVID symptoms&#x2014;A cardiologist&#x2019;s view. Front. Cardiovasc. Med. 2022;9:992686. doi: 10.3389/fcvm.2022.992686.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.992686</ArticleId><ArticleId IdType="pmc">PMC9520195</ArticleId><ArticleId IdType="pubmed">36186977</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt B., Schieffer B. Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites. J. Med. Chem. 2003;46:2261&#x2013;2270. doi: 10.1021/jm0204237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm0204237</ArticleId><ArticleId IdType="pubmed">12773029</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee for the REMAP-CAP Investigators Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support&#x2013;Free Days in Patients Hospitalized with COVID-19, A Randomized Clinical Trial. JAMA. 2023;329:1183&#x2013;1196. doi: 10.1001/jama.2023.4480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.4480</ArticleId><ArticleId IdType="pmc">PMC10326520</ArticleId><ArticleId IdType="pubmed">37039790</ArticleId></ArticleIdList></Reference><Reference><Citation>Self W.H., Shotwell M.S., Gibbs K.W., de Wit M., Files C., Harkins M., Hudock K.M., Merck L.H., Moskowitz A., Apodaca K.D., et al. Renin-Angiotensin System Modulation with Synthetic Angiotensin (1&#x2013;7) and Angiotensin II Type 1 Receptor&#x2013;Biased Ligand in Adults with COVID-19, Two Randomized Clinical Trials. JAMA. 2023;329:1170&#x2013;1182. doi: 10.1001/jama.2023.3546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.3546</ArticleId><ArticleId IdType="pmc">PMC10091180</ArticleId><ArticleId IdType="pubmed">37039791</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.M.Y., McMurray J.J.V. Lack of Benefit of Renin-Angiotensin System Inhibitors in COVID-19. JAMA. 2023;329:1155&#x2013;1156. doi: 10.1001/jama.2023.4405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.4405</ArticleId><ArticleId IdType="pubmed">37039803</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes R.D., Macedo A.V.S., de Barros E Silva P.G.M., Moll-Bernardes R.J., Feldman A., D&#x2019;Andr&#xe9;a Saba Arruda G., de Souza A.S., de Albuquerque D.C., Mazza L., Santos M.F., et al. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)&#x2013;The BRACE CORONA Trial. Am. Heart J. 2020;226:49&#x2013;59. doi: 10.1016/j.ahj.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7219415</ArticleId><ArticleId IdType="pubmed">32502882</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J.B., Hanff T.C., William P., Sweitzer N., Rosado-Santander N.R., Medina C., Rodriguez-Mori J.R., Renna N., Chang T.I., Corrales-Medina V., et al. Continuation versus discontinuation of renin&#x2013;angiotensin system inhibitors in patients admitted to hospital with COVID-19, A prospective, randomised, open-label trial. Lancet Respir. Med. 2021;9:275&#x2013;284. doi: 10.1016/S2213-2600(20)30558-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30558-0</ArticleId><ArticleId IdType="pmc">PMC7832152</ArticleId><ArticleId IdType="pubmed">33422263</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan Sui Ko A., Candellier A., Mercier M., Joseph C., Carette H., Basille D., Lion-Daolio S., Devaux S., Schmit J.L., Lanoix J.P., et al. No Impact of Corticosteroid Use During the Acute Phase on Persistent Symptoms Post-COVID-19. Int. J. Gen. Med. 2022;18:6645&#x2013;6651. doi: 10.2147/IJGM.S367273.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S367273</ArticleId><ArticleId IdType="pmc">PMC9394663</ArticleId><ArticleId IdType="pubmed">36003084</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung T.S., Liu D.X. Coronavirus infection, ER stress, apoptosis and innate immunity. Front. Microbiol. 2014;5:296. doi: 10.3389/fmicb.2014.00296.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2014.00296</ArticleId><ArticleId IdType="pmc">PMC4060729</ArticleId><ArticleId IdType="pubmed">24987391</ArticleId></ArticleIdList></Reference><Reference><Citation>Inde Z., Croker B.A., Yapp C., Joshi G.N., Spetz J., Fraser C., Qin X., Xu L., Deskin B., Ghelf E., et al. Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severity. Sci. Adv. 2021;7:8609&#x2013;8627. doi: 10.1126/sciadv.abf8609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abf8609</ArticleId><ArticleId IdType="pmc">PMC8373124</ArticleId><ArticleId IdType="pubmed">34407940</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleksova A., Ferro F., Gagno G., Cappelletto C., Santon D., Rossi M., Ippolito G., Zumla A., Beltrami A.P., Sinagra G. COVID-19 and renin-angiotensin system inhibition: Role of angiotensin converting enzyme 2 (ACE2)&#x2014;Is there any scientific evidence for controversy? J. Intern. Med. 2020;288:410&#x2013;421. doi: 10.1111/joim.13101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13101</ArticleId><ArticleId IdType="pmc">PMC7283873</ArticleId><ArticleId IdType="pubmed">32459372</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashraf U.M., Abokor A.A., Edwards J.M., Edwards J.M., Waigi E.W., Royfman R.S., Hasan S.A.M., Smedlund K.B., Gregio Hardy A.M., Chakravarti R., et al. SARS-CoV-2, ACE2 expression, and systemic organ invasion. Physiol. Genom. 2021;53:51&#x2013;60. doi: 10.1152/physiolgenomics.00087.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00087.2020</ArticleId><ArticleId IdType="pmc">PMC7900915</ArticleId><ArticleId IdType="pubmed">33275540</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Penninger J.M., Li Y., Zhong N., Slutsky A.S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586&#x2013;590. doi: 10.1007/s00134-020-05985-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05985-9</ArticleId><ArticleId IdType="pmc">PMC7079879</ArticleId><ArticleId IdType="pubmed">32125455</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A., Mukherjee S. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J. Med. Virol. 2020;92:2105&#x2013;2113. doi: 10.1002/jmv.25987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25987</ArticleId><ArticleId IdType="pmc">PMC7267663</ArticleId><ArticleId IdType="pubmed">32383269</ArticleId></ArticleIdList></Reference><Reference><Citation>Polidoro R.B., Hagan R.S., de Santis Santiago R., Schmidt N.W. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19. Front. Immunol. 2020;11:1626. doi: 10.3389/fimmu.2020.01626.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01626</ArticleId><ArticleId IdType="pmc">PMC7344249</ArticleId><ArticleId IdType="pubmed">32714336</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboudounya M.M., Heads R.J. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation. Mediat. Inflamm. 2021;2021:8874339. doi: 10.1155/2021/8874339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8874339</ArticleId><ArticleId IdType="pmc">PMC7811571</ArticleId><ArticleId IdType="pubmed">33505220</ArticleId></ArticleIdList></Reference><Reference><Citation>Recinos A., LeJeune W.S., Sun H., Lee C.Y., Tieu B.C., Lu M., Hou T., Boldogh I., Tilton R.G., Brasier A.R. Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice. Atherosclerosis. 2007;194:125&#x2013;133. doi: 10.1016/j.atherosclerosis.2006.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2006.10.013</ArticleId><ArticleId IdType="pmc">PMC2196437</ArticleId><ArticleId IdType="pubmed">17109863</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., Zhao T., Zhou X., Xiang Y., Gutierrez-Castrellon P., Ma X. Inflammatory pathways in COVID-19, Mechanism and therapeutic interventions. MedComm. 2022;3:e154. doi: 10.1002/mco2.154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mco2.154</ArticleId><ArticleId IdType="pmc">PMC9340488</ArticleId><ArticleId IdType="pubmed">35923762</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuadrado A., Nebreda A.R. Mechanisms and functions of p38 MAPK signalling. Biochem. J. 2010;429:403&#x2013;417. doi: 10.1042/BJ20100323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20100323</ArticleId><ArticleId IdType="pubmed">20626350</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimes J.M., Grimes K.V. p38 MAPK inhibition: A promising therapeutic approach for COVID-19. J. Mol. Cell. Cardiol. 2020;144:63&#x2013;65. doi: 10.1016/j.yjmcc.2020.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2020.05.007</ArticleId><ArticleId IdType="pmc">PMC7228886</ArticleId><ArticleId IdType="pubmed">32422320</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriram K., Insel P.A. A hypothesis for pathobiology and treatment of COVID-19, The centrality of ACE1/ACE2 imbalance. Br. J. Pharmacol. 2020;177:4825&#x2013;4844. doi: 10.1111/bph.15082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15082</ArticleId><ArticleId IdType="pmc">PMC7572451</ArticleId><ArticleId IdType="pubmed">32333398</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C., Kraft K. Oxidative Stress and HyperInflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of HighDose Intravenous Vitamin C. Front. Pharmacol. 2022;13:899198. doi: 10.3389/fphar.2022.899198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.899198</ArticleId><ArticleId IdType="pmc">PMC9100929</ArticleId><ArticleId IdType="pubmed">35571085</ArticleId></ArticleIdList></Reference><Reference><Citation>de las Heras N., Mart&#xed;n Gim&#xe9;nez V.M., Ferder L., Manucha W., Lahera V. Implications of Oxidative Stress and Potential Role of Mitochondrial Dysfunction in COVID-19, Therapeutic Effects of Vitamin D. Antioxidants. 2020;9:897. doi: 10.3390/antiox9090897.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9090897</ArticleId><ArticleId IdType="pmc">PMC7555731</ArticleId><ArticleId IdType="pubmed">32967329</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z., Zheng Z., Liu J. Comparison of COVID-19 and Lung Cancer via Reactive Oxygen Species Signaling. Front. Oncol. 2021;11:708263. doi: 10.3389/fonc.2021.708263.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.708263</ArticleId><ArticleId IdType="pmc">PMC8283805</ArticleId><ArticleId IdType="pubmed">34277453</ArticleId></ArticleIdList></Reference><Reference><Citation>Alobaidy A.S.H., Elhelaly M., Amer M.E., Shemies R.A., Othman A.I., El-Missiry M.A. Angiotensin converting enzyme 2 gene expression and markers of oxidative stress are correlated with disease severity in patients with COVID-19. Mol. Biol. Rep. 2023;50:5827&#x2013;5836. doi: 10.1007/s11033-023-08515-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-023-08515-0</ArticleId><ArticleId IdType="pmc">PMC10206357</ArticleId><ArticleId IdType="pubmed">37222866</ArticleId></ArticleIdList></Reference><Reference><Citation>Khazaal S., Harb J., Rima M., Annweiler C., Wu Y., Cao Z., Khattar Z.A., Legros C., Kovacic H., Fajloun Z., et al. The Pathophysiology of Long COVID throughout the Renin-Angiotensin System. Molecules. 2022;27:2903. doi: 10.3390/molecules27092903.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27092903</ArticleId><ArticleId IdType="pmc">PMC9101946</ArticleId><ArticleId IdType="pubmed">35566253</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakovac H., Feren&#x10d;i&#x107; A., Stemberger C., Mohar Vitezi&#x107; B., Cuculi&#x107; D. Detection of SARS-CoV-2 Antigens in the AV-Node of a Cardiac Conduction System&#x2014;A Case Report. Trop. Med. Infect. Dis. 2022;7:43. doi: 10.3390/tropicalmed7030043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed7030043</ArticleId><ArticleId IdType="pmc">PMC8955572</ArticleId><ArticleId IdType="pubmed">35324590</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavazzi G., Pellegrini C., Maurelli M., Belliato M., Sciutti F., Bottazzi A., Sepe P.A., Resasco T., Camporotondo R., Bruno R., et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur. J. Heart Fail. 2020;22:911&#x2013;915. doi: 10.1002/ejhf.1828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1828</ArticleId><ArticleId IdType="pmc">PMC7262276</ArticleId><ArticleId IdType="pubmed">32275347</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrofanova L.B., Makarov I.A., Gorshkov A.N., Runov A.L., Vonsky M.S., Pisareva M.M., Komissarov A.B., Makarova T.A., Li Q., Karonova T.L., et al. Comparative Study of the Myocardium of Patients from Four COVID-19 Waves. Diagnostics. 2023;13:1645. doi: 10.3390/diagnostics13091645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13091645</ArticleId><ArticleId IdType="pmc">PMC10178873</ArticleId><ArticleId IdType="pubmed">37175037</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojkova D., Wagner J.U.G., Shumliakivska M., Aslan G.S., Saleem U., Hansen A., Lux&#xe1;n G., G&#xfc;nther S., Duc Pham M., Krishnan J., et al. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovasc. Res. 2020;116:2207&#x2013;2215. doi: 10.1093/cvr/cvaa267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa267</ArticleId><ArticleId IdType="pmc">PMC7543363</ArticleId><ArticleId IdType="pubmed">32966582</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto A., Kawakami R., Kawai K., Gianatti A., Pellegrini D., Kutys R., Guo L., Mori M., Cornelissen A., Sato Y., et al. ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart. Arterioscler. Thromb. Vasc. Biol. 2021;41:542&#x2013;544. doi: 10.1161/ATVBAHA.120.315229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.315229</ArticleId><ArticleId IdType="pubmed">33086866</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Chen T., Zhou Y. Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes. Hereditas. 2021;158:4. doi: 10.1186/s41065-020-00168-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41065-020-00168-4</ArticleId><ArticleId IdType="pmc">PMC7781406</ArticleId><ArticleId IdType="pubmed">33397514</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Luo S., Libby P., Shi G.P. Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients. Pharmacol. Ther. 2020;213:107587. doi: 10.1016/j.pharmthera.2020.107587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2020.107587</ArticleId><ArticleId IdType="pmc">PMC7255230</ArticleId><ArticleId IdType="pubmed">32470470</ArticleId></ArticleIdList></Reference><Reference><Citation>Nappi F., Avtaar Singh S.S. Endothelial Dysfunction in SARS-CoV-2 Infection. Biomedicines. 2022;10:654. doi: 10.3390/biomedicines10030654.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10030654</ArticleId><ArticleId IdType="pmc">PMC8945463</ArticleId><ArticleId IdType="pubmed">35327455</ArticleId></ArticleIdList></Reference><Reference><Citation>Tucker N.R., Chaffin M., Bedi K.C., Jr., Papangeli I., Akkad A.D., Arduini A., Hayat S., Eraslan G., Muus C., Bhattacharyya R.P., et al. Myocyte-Specific Upregulation of ACE2 in Cardiovascular Disease. Circulation. 2020;142:708&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7424896</ArticleId><ArticleId IdType="pubmed">32795091</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Toro A., Bozzani A., Tavazzi G., Urtis M., Giuliani L., Pizzoccheri R., Aliberti F., Fergnani V., Arbustini E. Long COVID: Long-term effects? Eur. Hear J. Suppl. 2021;23:E1&#x2013;E5. doi: 10.1093/eurheartj/suab080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/suab080</ArticleId><ArticleId IdType="pmc">PMC8503490</ArticleId><ArticleId IdType="pubmed">34650349</ArticleId></ArticleIdList></Reference><Reference><Citation>Flammer A.J., Anderson T., Celermajer D.S., Creager M.A., Deanfield J., Ganz P., Hamburg N.M., L&#xfc;scher T.F., Shechter M., Taddei S., et al. The assessment of endothelial function: From research into clinical practice. Circulation. 2012;126:753&#x2013;767. doi: 10.1161/CIRCULATIONAHA.112.093245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.112.093245</ArticleId><ArticleId IdType="pmc">PMC3427943</ArticleId><ArticleId IdType="pubmed">22869857</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Turco S., Vianello A., Ragusa R., Caselli C., Basta G. COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge? Thromb. Res. 2020;196:143&#x2013;151. doi: 10.1016/j.thromres.2020.08.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.08.039</ArticleId><ArticleId IdType="pmc">PMC7451195</ArticleId><ArticleId IdType="pubmed">32871306</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur J.M., Forrest J.C., Boehme K.W., Kennedy J.L., Owens S., Herzog C., Liu J., Harville T.O. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS ONE. 2021;16:e0257016. doi: 10.1371/journal.pone.0257016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257016</ArticleId><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H., Zuo Y., Navaz S., Harbaugh A., Hoy C.K., Gandhi A.A., Sule G., Yalavarthi S., Gockman K., Madisonet J.A., et al. Endothelial Cell&#x2013;Activating Antibodies in COVID-19. Arthritis Rheumatol. 2022;74:1132&#x2013;1138. doi: 10.1002/art.42094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42094</ArticleId><ArticleId IdType="pmc">PMC9082472</ArticleId><ArticleId IdType="pubmed">35174669</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Liu Y., Wang X., Yang L., Li H., Wang Y., Liu M., Zhao X., Xie Y., Yang Y., et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J. Hematol. Oncol. 2020;13:120. doi: 10.1186/s13045-020-00954-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-020-00954-7</ArticleId><ArticleId IdType="pmc">PMC7471641</ArticleId><ArticleId IdType="pubmed">32887634</ArticleId></ArticleIdList></Reference><Reference><Citation>Team R.A. The microvascular hypothesis underlying neurologic manifestations of long COVID-19 and possible therapeutic strategies. Cardiovasc. Endocrinol. Metab. 2021;10:193&#x2013;203. doi: 10.1097/XCE.0000000000000253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/XCE.0000000000000253</ArticleId><ArticleId IdType="pmc">PMC8575441</ArticleId><ArticleId IdType="pubmed">34765889</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallejo Camaz&#xf3;n N., Teis A., Mart&#xed;nez Membrive M.J., Llibre C., Bay&#xe9;s-Gen&#xed;s A., Mateu L. Long COVID-19 and microvascular disease-related angina. Rev. Esp. Cardiol. 2022;75:444&#x2013;446. doi: 10.1016/j.recesp.2021.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.recesp.2021.10.011</ArticleId><ArticleId IdType="pmc">PMC8639437</ArticleId><ArticleId IdType="pubmed">34876772</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Strieter R.M., Mehrad B. New mechanisms of pulmonary fibrosis. Chest. 2009;136:1364&#x2013;1370. doi: 10.1378/chest.09-0510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.09-0510</ArticleId><ArticleId IdType="pmc">PMC2773361</ArticleId><ArticleId IdType="pubmed">19892675</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Zheng X., Tong Q., Li W., Wang B., Sutter K., Trilling M., Dittmer M.U., Yang D. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J. Med. Virol. 2020;92:491&#x2013;494. doi: 10.1002/jmv.25709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25709</ArticleId><ArticleId IdType="pmc">PMC7166760</ArticleId><ArticleId IdType="pubmed">32056249</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez-Garc&#xed;a L.A., Escobedo G., Minguer-Uribe A.G., Viurcos-Sanabria R., Aguayo-Guerrero J.A., Carrillo-Ruiz J.D., Solleiro-Villavicencio H. Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations. Front. Cell Neurosci. 2022;16:977039. doi: 10.3389/fncel.2022.977039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2022.977039</ArticleId><ArticleId IdType="pmc">PMC9523599</ArticleId><ArticleId IdType="pubmed">36187294</ArticleId></ArticleIdList></Reference><Reference><Citation>Piersma B., Bank R.A., Boersema M. Signaling in Fibrosis: TGF-&#x3b2;, WNT, and YAP/TAZ Converge. Front. Med. 2015;2:59. doi: 10.3389/fmed.2015.00059.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2015.00059</ArticleId><ArticleId IdType="pmc">PMC4558529</ArticleId><ArticleId IdType="pubmed">26389119</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Malaspina H., Rabellino E.M., Yen A., Nachman R.L., Moore M.A. Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood. 1981;57:781&#x2013;787. doi: 10.1182/blood.V57.4.781.781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V57.4.781.781</ArticleId><ArticleId IdType="pubmed">7470627</ArticleId></ArticleIdList></Reference><Reference><Citation>George P.M., Wells A.U., Jenkins R.G. Pulmonary fibrosis and COVID-19, The potential role for antifibrotic therapy. Lancet Respir. Med. 2020;8:807&#x2013;815. doi: 10.1016/S2213-2600(20)30225-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30225-3</ArticleId><ArticleId IdType="pmc">PMC7228727</ArticleId><ArticleId IdType="pubmed">32422178</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitto N., Liguori E., La Mura V. Coagulation, Microenvironment and Liver Fibrosis. Cells. 2018;7:85. doi: 10.3390/cells7080085.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells7080085</ArticleId><ArticleId IdType="pmc">PMC6115868</ArticleId><ArticleId IdType="pubmed">30042349</ArticleId></ArticleIdList></Reference><Reference><Citation>Thille A.W., Esteban A., Fern&#xe1;ndez-Segoviano P., Rodriguez J.M., Aramburu J.A., Vargas-Errazuriz P., Martin-Pellicer A., Lorente J.A., Frutos-Vivar F. Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: A prospective cohort study of clinical autopsies. Lancet Respir. Med. 2013;1:395&#x2013;401. doi: 10.1016/S2213-2600(13)70053-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(13)70053-5</ArticleId><ArticleId IdType="pubmed">24429204</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W.T., Akhter H., Jiang C., MacEwen M., Ding Q., Antony V., Thannickal V.J., Liu R.M. Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosis. Exp. Gerontol. 2015;61:62&#x2013;75. doi: 10.1016/j.exger.2014.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2014.11.018</ArticleId><ArticleId IdType="pmc">PMC4384687</ArticleId><ArticleId IdType="pubmed">25451236</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataraman T., Frieman M.B. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antivir. Res. 2017;143:142. doi: 10.1016/j.antiviral.2017.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.03.022</ArticleId><ArticleId IdType="pmc">PMC5507769</ArticleId><ArticleId IdType="pubmed">28390872</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj V.S., Mou H., Smits S.L., Dekkers D.H.W., Muller M.A., Dijkman R., Muth D., Demmers J.A.A., Zaki A., Fouchier R.A.M., et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495:251&#x2013;254. doi: 10.1038/nature12005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12005</ArticleId><ArticleId IdType="pmc">PMC7095326</ArticleId><ArticleId IdType="pubmed">23486063</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T., Tanaka K., Fujita T., Umezawa H., Amano H., Yoshioka K., Naito Y., Hatano M., Kimura S., Tatsumi K., et al. Bidirectional role of IL-6 signal in pathogenesis of lung fibrosis. Respir. Res. 2015;16:99. doi: 10.1186/s12931-015-0261-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-015-0261-z</ArticleId><ArticleId IdType="pmc">PMC4546032</ArticleId><ArticleId IdType="pubmed">26289430</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>